cross-reacting antibodies enhance dengue virus infection humans 
dengue virus co-circulates four serotypes sequential infections one serotype common one hypothesis increased severity seen secondary infections antibody-dependent enhancement ade leading increased replication fc receptor-bearing cells study generated panel human monoclonal antibodies dengue virus antibodies structural precursor-membrane protein prm form major component response antibodies highly cross-reactive among dengue virus serotypes even high concentrations neutralize infection potently promote ade propose partial cleavage prm viral surface reduces density antigen available viral neutralization leaving dengue viruses susceptible ade antibody prm finding implications future vaccine design 
